Vascular Reactivity in Atopic Eczema

  • T. J. Ryan

Abstract

The term “atopy” describes the altered reactivity characteristic of asthma, hayfever and eczema. These are common problems tending to run in families, and especially affecting children. The principal manifestations involving the lung, nose or skin have attracted an enormous volume of literature. That the blood vessels play some part in the mechanisms underlying the disorder is clear, especially in the congested and oedematous nasal mucosa of hayfever and the urticarial response and vasodilation in eczema, but less obviously so in asthma. Infact, urticaria was a prominant feature in 11% of children in one large French study [78]. The contribution of a raised surface temperature to itch is also important in the skin.

Keywords

Aspirin Noradrenaline Choline Thrombin Acetyl 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aizawa H, Tagami H (1989) Inhability to produce white dermographism in the early stage of infantile eczema. Pediatr Dermatol 6: 6–9PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous (1988) Editorial. Lancet 2: 19–20Google Scholar
  3. 3.
    Archer CB, Dalton N, Turner C, Mac Donald DM (1987) Investigation of adrenomedullary function in atopic dermatitis. Br J Dermatol 116; 793–800Google Scholar
  4. 4.
    Archer CB, Markey AC, Barker JNWN, Lee TH, MacDonald DM (1989) Effects of the platelet activating factor (PAF) antagonist BN5 2063 on the clinical and histological responses to PAF in atopic skin. J Invest Dermatol 92: 397Google Scholar
  5. 5.
    Ashton RE, Russell Jones R, Griffiths A (1985) Juvenile plantar dermatosis: a clinicophathologic study. Arch Dermatol 121: 225–8PubMedCrossRefGoogle Scholar
  6. 6.
    Baer RL (1985) Papaverine therapy in atopic dermatitis. J Am Acad Dermatol 13: 806–808PubMedCrossRefGoogle Scholar
  7. 7.
    Bertelli A (1968) Proteases and anti-proteasic substances in the inflammatory response. Biochem Pharmacol [Suppl] 229Google Scholar
  8. 8.
    Brain SD, Williams TJ (1988) Substance P regulates vasodilator activity of calcitonin gene related peptide. Nature 335: 73–75PubMedCrossRefGoogle Scholar
  9. 9.
    Brain SD, Tippins JR, Morris HR, McIntyre I, Williams TJ (1986) Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 87: 533–536PubMedCrossRefGoogle Scholar
  10. 10.
    Brotherton AFA, Hoak JC (1982) Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium. Proc Natl Acad Sci USA 79: 495–499PubMedCrossRefGoogle Scholar
  11. 11.
    Brotherton AFA, MacFarlane DE, Hoak JC (1982) Prostacyclin biosynthesis is not inhibited by cyclic AMP. Studies with 3-isobutyl-1-methylxanthine and forskolin. Thromb Res 28: 637–647PubMedCrossRefGoogle Scholar
  12. 12.
    Brown J, Perry P, Ansel J (1989) Substance P induction of keratinocyte cytokines. J Invest Dermatol 92: 407Google Scholar
  13. 13.
    Bull HA, Rustin MHA, Dowd PM (1989) Release of prostacyclin from cultured human endothelial cells following prolonged exposure to histamine Br J Dermatol 120: 757–765Google Scholar
  14. 14.
    Burn JH (1961) A new view of adrenergic nerve fibres, explaining the action of reserpine, bretylium and guanethidine. Br Med J 1: 1623–628PubMedCrossRefGoogle Scholar
  15. 15.
    Burn JH, Rand MJ (1960) The relation of circulating noradrenaline to the effect of sympathetic stimulation. J Physiol 150: 295–305PubMedGoogle Scholar
  16. 16.
    Cavender DE, Haskard DO, Joseph B, Ziff M (1986) Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 136: 203–207PubMedGoogle Scholar
  17. 17.
    Champion RH (1963) Vascular reactions in atopic eczema. Br J Dermatol 75: 12–15PubMedCrossRefGoogle Scholar
  18. 18.
    Charo IF, Karasek MA, Davison PM, Goldstein IM (1984) Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. J Clin Invest 74: 914–919PubMedCrossRefGoogle Scholar
  19. 19.
    Christophers E, Henseler T (1987) Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res 48 [Suppl 5]: 551Google Scholar
  20. 20.
    Cooper KD (1988) Atopic eczema. In. Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin, Heidelberg, New York, p 280Google Scholar
  21. 21.
    Copeman PWM, Winkelman RK (1969) Vascular changes accompanying white dermographism and delayed blanch in atopic dermatitis. Br J Dermatol 81: 944–945PubMedCrossRefGoogle Scholar
  22. 22.
    Coulson IH, Duncan SN, Holden CA (1989) Peripheral blood mononuclear leukocyte cyclic AMP specific phosphodiesterase activity in childhood atopic dermatitis. Br J Dermatol 120: 607–612PubMedCrossRefGoogle Scholar
  23. 23.
    Czervionke RL, Smith JB, Fry GL, Hoak JC, Haycraft DL (1979) Inhibition of prostacyclin by treatment of endothelium with aspirin. J Clin Invest 63: 1089–1092PubMedCrossRefGoogle Scholar
  24. 24.
    David MJ, Lawler JC (1958) Observations on delayed blanch phenomenon in atopic subjects. J Invest Dermatol 30: 127Google Scholar
  25. 25.
    Di Palma JR, Reynolds SRM, Foster FI (1942) Quantitative measurement of reactive hyperemia in human skin. Individual and seasonal variation. Am Heart J 23: 377–389Google Scholar
  26. 26.
    Englehardt A (1965) Gefäßreaktionen bei verschiedenen Formen des mikrobiell-seborrhoischen Ekzems als nosologischen Ordnungsprinzips. Arch Klin Exp Dermatol 223: 16Google Scholar
  27. 27.
    English JS, Winkelmann RK, Louback et al. (1987) The cellular inflammatory response in nicotinate skin reaction. Br J Dermatol 116: 341–349PubMedCrossRefGoogle Scholar
  28. 28.
    Fogh, K, HerlinTand Kragballe K (1989) Eicosanoids in skin of patients with atopic dermatitis; prostaglandin E2 and leukotriene B4 are present in biologically active concentration. J Allergy Clin Immunol 83: 450–455PubMedCrossRefGoogle Scholar
  29. 29.
    Frangos JA, Eskin SG, McIntyre LV, Ives CI (1985) Flow effects on prostacyclin production by cultured human endothelial cells. Science 227: 1477–1479PubMedCrossRefGoogle Scholar
  30. 30.
    Fuller RW, Conradson TB, Dixon CMS (1987) Sensory neuropeptide effects on human skin. Br J Dermatol 92: 781Google Scholar
  31. 31.
    Giannetti A, Girolomoni G (1989) Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121: 681–688PubMedCrossRefGoogle Scholar
  32. 32.
    Grabowski EF, Jaffe EA, Weksler BB (1985) Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress. J Lab Clin Med 105: 36–43PubMedGoogle Scholar
  33. 33.
    Graham DT, Wolf S (1953) The relation of eczema to attitude and vascular reactions of the human skin. J Lab Clin Med 42: 238PubMedGoogle Scholar
  34. 34.
    Gresele P, Bounameaux H, Arnout J, Perez-Requejo JL, Deckmyn H, Vermylen J (1985) Thromboxane A2 and prostacyclin do not modulate the systemic haemodynamic response to cold in humans. J Lab Clin Med 106: 534–541PubMedGoogle Scholar
  35. 35.
    Grewe SR, Chan SC, Hanifan JM (1982) Elevated leukocyte cyclic AMP phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP agonist hypo-responsiveness. J Allergy Clin Immunol 70: 452–457PubMedCrossRefGoogle Scholar
  36. 36.
    Hanss M, Collen D (1987) Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxon, and histamine. J Lab Clin Med 109: 97–104PubMedGoogle Scholar
  37. 37.
    Hatano H, Yamamoto K, Kono N (1962) Studies on fibrinolytic enzyme system in dermatology: local antifibrinolytic activity in several skin diseases. Keio J Med 11: 167CrossRefGoogle Scholar
  38. 38.
    Haustein UF (1968) Quantitative Bestimmung des Gewebsaktivators der Fibrinolyse in gesunder and kranker Haut. Arch Klin Exp Dermatol 232: 245PubMedGoogle Scholar
  39. 39.
    Haustein UF (1969) Die Lokalisation des Gewebsaktiva-tors der Fibrinolyse bei Dermatosen. Arch Klin Exp Dermatol 234: 182PubMedGoogle Scholar
  40. 40.
    Heyer G, Schonberger A, Hornstein OP (1988) Disturbances of thermoregulation following warm and cold exposure in patients with atopic eczema. Hautarzt 39: 18–22PubMedGoogle Scholar
  41. 41.
    Hill HR, Quie PG (1974) Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1: 183PubMedCrossRefGoogle Scholar
  42. 42.
    Hirschberg H, Bergh OJ, Thorsby E (1980) Antigen-presenting properties of human vascular endothelium. J Exp Med 152: 249s - 255sPubMedCrossRefGoogle Scholar
  43. 43.
    Hong SL, Deykin D (1982) Activation of phospholipases A2 and C in pig aortic endothelial cells synthesizing prosacyclin. J Biol Chem 257: 7151–7154PubMedGoogle Scholar
  44. 44.
    Hoover RL, Folger R, HaeringWA, Ware BR, Kamovsky MJ (1980) Adhesion of leucocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate. J Cell Sci 45: 73–86PubMedGoogle Scholar
  45. 45.
    Hoover RL, Karnovsky MJ, Ausren KF, Corey EJ, Lewis RA (1984) Leukotriene B4 action on endothelium mediates augmented neutrophil endothelial adhesion. Proc Natl Acad Sci USA 81: 2191–2193PubMedCrossRefGoogle Scholar
  46. 46.
    Horiuchi Y, Ryan TJ (1987) Phorbol ester stimulates urokinase inhibitor synthesis by cultured human fibroblasts. Br J Dermatol 116: 419–420Google Scholar
  47. 47.
    Hornqvist R, Bäck O, Henriksson R (1984) Adrenoceptor-mediated responses in human skin studied by iontophoresis. Br J Dermatol 111: 561–566PubMedCrossRefGoogle Scholar
  48. 48.
    Hörnqvist R, Henriksson R, Bäck O (1988) Iontophoretic study of skin vessel reactivity in atopic dermatitis and its correlation to serum IgE levels. J Am Acad Dermatol 18: 269–274PubMedCrossRefGoogle Scholar
  49. 49.
    Jancso G, Obal F, Tothkasa I, Katona M, Husz S (1985) The modulation of cutaneous inflammatory reactions by peptide containing sensory nerves. Int J Tissure React 7: 449–457Google Scholar
  50. 50.
    Juhlin L (1962) Vascular skin reactions in atopic dermatitis. Acta Derm Venereol (Stockh.) 42: 218–229Google Scholar
  51. 51.
    Juhlin L, Michaelsson G (1969) Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol (Stockh.) 49: 251–261Google Scholar
  52. 52.
    Kaltz F, Fekete Z (1960) Studies on the mechanism of the white response and of the delayed blanch phenomenon in atopic subjects by means of coomassie blue. J Invest Dermatol 35: 251Google Scholar
  53. 53.
    Kemmett D (1989) Premenstrual exacerbation of atopic dermatitis. Br J Dermatol 120: 715–718PubMedCrossRefGoogle Scholar
  54. 54.
    Kepecs JG, Robin M, Brunner MJ (1951) Relationship between certain emotional states with exudation into the skin. Psychosom Med 13: 10PubMedGoogle Scholar
  55. 55.
    Kottegoda SR (1953) The action of nicotine and acetylcholine on the vessels of the rabbit’s ear. Br J Dermatol 8: 156–161Google Scholar
  56. 56.
    Leung DYM, Bhaw AK, Schneeberger EE et al. (1983) Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 71: 47PubMedCrossRefGoogle Scholar
  57. 57.
    Lewis T (1927) The blood vessels of the human skin and their responses. Shaw and Sons, LondonGoogle Scholar
  58. 58.
    Lobitz WC, Campbell CJ (1953) Physiologic studies in atopic dermatitis (disseminated neurodermatitis) I. The local cutaneous response to intradermally injected acetylcholine and epinephrine. Arch Dermatol Syphilol 67: 575Google Scholar
  59. 59.
    Lovell CR, Burton JL, Horrobin DF (1981) Treatment of atopic eczema with evening primrose oil. Lancet 2: 1120Google Scholar
  60. 60.
    MacMillan A (1969) Delayed blanch and opacity pulse. Br J Dermatol 81: 631CrossRefGoogle Scholar
  61. 61.
    Mallet AI, Camp RDR, Rendell NB, Ross JS, Mitchell M, Greaves MW (1989) Measurement of levels of histamine and its major metabolite in the urine of atopic dermatitis patients. J Invest Dermatol 92: 475Google Scholar
  62. 62.
    Marone G, Giugliano R, Lembo G, Ayala F (1986) Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 87: 19–23Google Scholar
  63. 63.
    Masuda T, Naito A, Kinoshita M et al. (1967) Acetylcholine inhalation test in atopic dermatitis. J Allergy 40: 193PubMedCrossRefGoogle Scholar
  64. 64.
    Maurice PDL, Barr RM, Koro O, Greaves MW (1987) The effect of prostaglandin D2 on the response of human skin to histamine. J Invest Dermatol 89: 245–248PubMedCrossRefGoogle Scholar
  65. 65.
    Maxwell RA, Plummer AJ, Schneider F, Povalski H, Daniel AJ (1960) Pharmacology of 2-(octahydro-Iazocinyl)-ethyl-guanidine sulfate (SU-5864). J Pharmacol Exp Ther 128: 22–29PubMedGoogle Scholar
  66. 66.
    Michaelsson G (1970) Decreased cutaneous reactions to kallikrein in patients with atopic dermatitis and psoriasis. Acta Derm Venereol (Stockh.) 50: 37–41Google Scholar
  67. 67.
    Mihm M, Soter NA, Dvorak HF et al. (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305PubMedCrossRefGoogle Scholar
  68. 68.
    Möller H, Rorsman H (1958) Studies on vascular permeability factors with sodium fluorescein. II. The effect of intracutaneously injected histamine and serum in patients with atopic dermatitis. Acta Derm Venereol (Stockh.) 38: 243Google Scholar
  69. 69.
    Moncada S, Gryglewski RJ, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665PubMedCrossRefGoogle Scholar
  70. 70.
    Moulin G, Manuel Y (1964) Étude immuno-électrophorétique comparative des protéines du sérum et du liquide des bulles dans les dermatoses bulleuses (60 observations). Ann Dermatol Syphilig. 91: 505–11Google Scholar
  71. 71.
    Murad F (1986) Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 78: 1–5PubMedCrossRefGoogle Scholar
  72. 72.
    Needleman P, Bronson SD, Wyche A, Sivakoff M, Nicoloau KC (1978) Cardiac and renal prostaglandin 12.J Clin Invest 839: 849Google Scholar
  73. 73.
    Neri Semen GG, Abbate R, Gensini GF, Galanti G, Paoli G, Laureano R (1982) Platelet aggregation and thromboxane A2 production after adrenergic stimulation in young healthy humans. Haemostasis 11: 40–48Google Scholar
  74. 74.
    Olive JT, Connell JO, Winkelmann RK, Logan GB (1970) Delayed blanch phenomenon in children: re-evaluation of 5-year old children originally tested as newborn. J Invest Dermatol 54: 256PubMedCrossRefGoogle Scholar
  75. 75.
    Palmer RMJ, Ferrige AG, Moncada S (1987) Release of nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526PubMedCrossRefGoogle Scholar
  76. 76.
    Parker CW, Kennedy S, Eisen AZ (1977) Leukocyte and lymphocyte cyclic AMP responses in atopic eczema. J Invest Dermatol 68: 302–306PubMedCrossRefGoogle Scholar
  77. 77.
    Perera P, Kurban AK, Ryan TJ (1970) The development of the cutaneous microvascular system in the newborn. Br J Dermatol 82 [Suppl 5]: 86–91CrossRefGoogle Scholar
  78. 78.
    Queille-Roussel C, Raynaud F, Saurat JH (1985) A prospective computerized study of 500 cases of atopic dermatitis in childhood. 1. Initial analysis of 250 parameters. Acta Derm Venereol (Stockh.) 114 [Suppl]Google Scholar
  79. 79.
    Ramsey C (1969) Vascular changes accompanying white dermographism and delayed blanch in atopic dermatitis. Br J Dermatol 81: 37CrossRefGoogle Scholar
  80. 80.
    Reed WB, Kierland RR (1958) Vascular reactions in chronically inflamed skin. II. Action of epinephrine and phentolamine (Regitine): action of acetylcholine and methacholine (Mecholyl), and the “delayed blanch”. A, M, A, Arch Derm 77: 181–186Google Scholar
  81. 81.
    Reed CE, Busse WW, Ping Lee T (1976) Adrenergic mechanisms and the adenyl cyclase system in atopic dermatitis. J Invest Dermatol 67: 333–338PubMedCrossRefGoogle Scholar
  82. 82.
    Reitamo S, Visa K, Kahonen K (1986) Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens. Br J Dermatol 114: 303–309PubMedCrossRefGoogle Scholar
  83. 83.
    Ring J (1988) In: Orfanos CE, Stadler R, Gollnick H (eds) Dermatology in five continents. Springer, Berlin, Heidelberg, New York, p 281Google Scholar
  84. 84.
    Ryan Ti (1967) A new technique for studying the microcirculation of the skin In: Bourne GH (ed) In Vivo. Techniques in histology. Williams and Wilkins, Baltimore, pp 192–202Google Scholar
  85. 85.
    Ryan TJ (1977) Urticaria and fibrinolysis. Clin Exp Dermatol 2: 177–182PubMedCrossRefGoogle Scholar
  86. 86.
    Ryan TJ (1984) Microcirculation in psoriasis: blood vessels, lymphatics and tissue fluid. Section 110. In: Baden HP (ed) The chemotherapy of psoriasis. Pergamon, Oxford, pp 145–184Google Scholar
  87. 87.
    Ryan TJ (1989) Biochemical consequences of mechanical forces generated by distension and distortion. J Am Acad Dermatol 21: 115–130PubMedCrossRefGoogle Scholar
  88. 88.
    Ryan TJ (1989) The cutaneous adipose tissue in. Clin Dermatol 7: 1–164PubMedCrossRefGoogle Scholar
  89. 89.
    Ryan TJ, Nishioka K, Dawber RPR (1971) Epithelial-endothelial interaction in the control of inflammation through fibrinolysis. Br J Dermatol 84: 501PubMedCrossRefGoogle Scholar
  90. 90.
    Ryan US (1988) Endothelial cells I. CRC, Boca RatonGoogle Scholar
  91. 91.
    Sampson HA, Jolie PL (1984) Increased plasma histamine concentrations after food challenge in children with atopic dermatitis. New Engl J Med 311: 372–376PubMedCrossRefGoogle Scholar
  92. 92.
    Schafer AI, Crawford DD, Gimbrone MA (1984) Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. J Clin Invest 73: 1105–1112PubMedCrossRefGoogle Scholar
  93. 93.
    Schonberger A, Langestein B, Heyer G, Hornstein OP (1988) A method of quantifying dermatographism in atopic eczema. Hautarzt 39: 72–76PubMedGoogle Scholar
  94. 94.
    Scott A (1960) Acetyl cholinesterase responses in physiological and pathological vasomotor reactions. In: Rook A (ed) Progress in biological sciences in relation to dermatology. Cambridge University Press, CambridgeGoogle Scholar
  95. 95.
    Scott A (1962) Acetylcholine in normal and diseased skin. Br J Dermatol 74: 317PubMedCrossRefGoogle Scholar
  96. 96.
    Sedlis E, Prose P (1959) Infantile eczema with special reference to the pathologic lesion. Pediatrics 23: 802PubMedGoogle Scholar
  97. 97.
    Seid JM, Macneil S, Tomlinson S (1983) Calcium, calmodulin and the production of prostacyclin by cultured vascular endothelial cells. Biosci Rep 3: 1007–1015PubMedCrossRefGoogle Scholar
  98. 98.
    Spector AA, Hoak JC, Denning GM, Stoll LL (1980) Effect of fatty acid modification on prostacyclin production by cultured human endothelial cells. J Clin Invest 65: 1003–1012PubMedCrossRefGoogle Scholar
  99. 99.
    Sventivanyi A (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. JAllergy 42: 203Google Scholar
  100. 100.
    Thune P, Rajka G (1980) Small vessel reactivity in atopic dermatitis. Acta Derm Venereol 30 [Suppl 92]: 30–32Google Scholar
  101. 101.
    Thune P, Ryan TJ, Powell SM, Ellis JR (1976) The cutaneous reactions to kallikrein, prostaglandin and thurfyl nicotinate in chronic urticaria and the effect of polyphloretin phosphate. Acta Derm Venereol 56: 217–221PubMedGoogle Scholar
  102. 102.
    Turner R, Kurban AK, Ryan TJ (1969) Fibrinolytic activity in human skin following epidermal injury. J Invest Dermatol 53 (6)Google Scholar
  103. 103.
    Uehara M (1982) Reduced histamine reaction in atopic dermatitis. Arch Dermatol 118: 244–245PubMedCrossRefGoogle Scholar
  104. 104.
    Uehara M, Ofuji S (1977) Abnormal vascular reactions in atopic dermatitis. Arch Dermatol 113: 627PubMedCrossRefGoogle Scholar
  105. 105.
    Von der Helm, Ring J, Dorsch WE (1987) Comparison of histamine release and prostaglandin E2 production of human basophils in atopic and normal individuals. Arch Dermatol Res 279: 536–542PubMedCrossRefGoogle Scholar
  106. 106.
    Wallis WJ, Hickstein DD, Schwartz BR, June CH, Ochs HD, Beatty PG, Klebanoff SJ et al. (1986) Monoclonal antibody defined functional epitopes on the adhesion-promoting glycoprotein complex (CDw18) of human neutrophils. Blood 67: 1007–1013PubMedGoogle Scholar
  107. 107.
    Wheeler ME, Bevilaqua MP, Luscinskas FW, Brock AF, Gimbrone MA (1986) Interleukin-1 treated endothelial cells produce an inhibitor of leukocyte-endothelial adhesion. Fed Proc 45: 450Google Scholar
  108. 108.
    Whorton AR, Willis CE, Kent RS, Young SL (1984) The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells. Lipids 19: 17–24PubMedCrossRefGoogle Scholar
  109. 109.
    Wilkin JK, Fortner G, Reinhardt LA, Flowers OV, Kilpatrick SJ (1985) Prostaglandins and nicotinate–provoked increase in cutaneous blood flow. Clin Pharmacol Ther 38: 273–277PubMedCrossRefGoogle Scholar
  110. 110.
    Winkelmann RK, Wilhelmj CM, Homer FA (1965) Experimental studies on dermographism. Arch Dermatol 92: 436PubMedCrossRefGoogle Scholar
  111. 111.
    Yamamoto K (1967) The fibrinolysis system (plasmin system) in atopic dermatitis. Speculation of kinin formation. J Clin Dermatol 21: 1257–1263Google Scholar
  112. 112.
    Yen A, Barrett KE, Gigli I (1989) Photoactivation of rat peritoneal mast cells suppresses histamine release induced by compound 48/80 and calcium ionphore A23187. J Invest Dermatol 92: 546 (abstract)Google Scholar
  113. 113.
    Yu CL, Haskard DO, Cavender D, Johnson AR, Ziff M (1985) Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol 62: 554–560PubMedGoogle Scholar
  114. 114.
    Yu CL, Haskard DO, Cavender D, Ziff M (1986) Effects of lipolysaccharide on the binding of lymphocytes to endothelial cell monolayers. J Immunol 136: 569–573PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • T. J. Ryan

There are no affiliations available

Personalised recommendations